US Broker Ratings

Corcept Therapeutics (CORT) Investor Outlook: Analyzing a 61% Potential Upside in the Biotech Sector

Corcept Therapeutics Incorporated (NASDAQ: CORT) offers a compelling opportunity for investors seeking exposure in the biotechnology sector, particularly given its robust pipeline of treatments targeting severe..

Summit Therapeutics Inc. (SMMT): Investor Outlook with a 55% Potential Upside

Summit Therapeutics Inc. (NASDAQ: SMMT), a pioneering player in the biotechnology sector, is drawing investor attention with its substantial market cap of $15.56 billion and a..

Amgen Inc. (AMGN) Stock Analysis: Exploring a 14.17% Upside Potential and Robust Revenue Growth

Amgen Inc. (NASDAQ: AMGN) stands as a beacon in the biopharmaceutical industry, delivering innovative human therapeutics with a market capitalization of $146.96 billion. As an integral..

AptarGroup, Inc. (ATR) Stock Analysis: Discover Its 33.69% Potential Upside

AptarGroup, Inc. (NYSE: ATR), a leading player in the healthcare sector, specifically within the Medical Instruments & Supplies industry, has been capturing investor attention with a..

Bristol-Myers Squibb (BMY) Stock Analysis: Exploring a 20% Upside Potential Amidst Strong Dividend Yield

Bristol-Myers Squibb Company (NYSE: BMY), a stalwart in the healthcare sector, continues to be an intriguing proposition for investors seeking both stability and potential growth in..

Bio-Techne Corp (TECH) Stock Analysis: 26.65% Potential Upside in the Biotechnology Sector

Bio-Techne Corp (NASDAQ: TECH) stands as a prominent player in the biotechnology sector, commanding a significant presence in the healthcare industry with a market capitalization of..

Danaher Corporation (DHR) Stock Analysis: Unpacking a 31.76% Potential Upside

As investors seek opportunities in the dynamic healthcare sector, Danaher Corporation (NYSE: DHR) presents a compelling case with a notable potential upside of 31.76%. With a..

Qiagen N.V. (QGEN) Investor Outlook: Assessing the 18% Upside Potential

Qiagen N.V. (NYSE: QGEN), a powerhouse in the Diagnostics & Research industry, headquartered in Venlo, Netherlands, is attracting investor attention with its promising growth prospects and..

Henry Schein, Inc. (HSIC) Stock Analysis: Exploring a Potential 10.85% Upside for Investors

Henry Schein, Inc. (HSIC), a leader in the healthcare sector, stands as a formidable force within the medical distribution industry. Headquartered in Melville, New York, and..

Labcorp Holdings Inc. (LH) Stock Analysis: Navigating Growth and Investor Confidence

Labcorp Holdings Inc. (NYSE: LH), a prominent player in the healthcare sector’s Diagnostics & Research industry, stands as a leading provider of laboratory services. With a..

Zimmer Biomet Holdings, Inc. (ZBH) Stock Report: Analyzing Growth Potential and Market Position

Zimmer Biomet Holdings, Inc. (NYSE: ZBH), a prominent player in the healthcare sector, is gaining attention for its robust market presence and growth potential. With a..

HCA Healthcare, Inc. (HCA) Stock Analysis: Strong ROE and Revenue Growth Drive Investor Interest

HCA Healthcare, Inc. (NYSE: HCA) continues to capture the attention of investors with its formidable presence in the U.S. healthcare sector. With a market capitalization of..

Novartis AG (NVS) Stock Analysis: Evaluating Growth Potential Amid Robust Revenue and Dividend Yield

Novartis AG (NYSE: NVS), a titan in the healthcare sector, continues to be a focal point for investors looking to capitalize on the pharmaceutical industry’s evolving..

United Therapeutics Corporation (UTHR) Stock Analysis: Exploring a Potential 11.69% Upside Amid Strong Revenue Growth

United Therapeutics Corporation (NASDAQ: UTHR), a powerhouse in the biotechnology sector, has been drawing significant attention from investors due to its robust pipeline and solid market..

Masimo Corporation (MASI) Stock Analysis: Uncovering a 32.65% Potential Upside in the Healthcare Sector

Masimo Corporation (NASDAQ: MASI), a prominent player in the healthcare sector, is capturing attention with its innovative medical devices and a promising 32.65% potential upside for..

Insmed Incorporated (INSM) Stock Analysis: A Biotech Powerhouse with 16% Upside Potential

Insmed Incorporated (NASDAQ: INSM), a prominent player in the biotechnology sector, is capturing investor attention with its innovative advancements in treating serious and rare diseases. With..

Alcon Inc. (ALC) Stock Analysis: Exploring a 32% Potential Upside in the Eye Care Giant

Alcon Inc. (NYSE: ALC), a Swiss-based titan in the healthcare sector, is making waves in the medical instruments and supplies industry with its robust portfolio of..

Revvity, Inc. (RVTY) Stock Analysis: A 37.77% Potential Upside in the Healthcare Diagnostics Arena

Investors seeking to navigate the complex landscape of healthcare diagnostics may find Revvity, Inc. (NYSE: RVTY) an intriguing prospect. Following its rebranding from PerkinElmer, Inc. in..

Solventum Corporation (SOLV) Stock Analysis: Unpacking a 20.85% Potential Upside

Solventum Corporation (SOLV), a prominent name in the healthcare sector, has caught the attention of investors with its promising potential upside of 20.85%. Specializing in medical..

Molina Healthcare Inc (MOH) Stock Analysis: Navigating Market Volatility with Strategic Growth

Molina Healthcare Inc (NYSE: MOH), a prominent player in the Healthcare Plans industry, is gaining attention from investors seeking value in a volatile market. Based in..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds